先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2014, vol.6, no.1 2014, vol.6, no.2 2014, vol.6, no.3 2014, vol.6, no.4 2014, vol.6, no.5 2014, vol.6, no.6

题名作者出版年年卷期
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockadeKaren Silence;Torsten Dreier;Mahan Moshir;Peter Ulrichts;Sofie ME Gabriels;Michael Saunders;Harald Wajant;Peter Brouckaert;Leander Huyghe;Tim Van Hauwermeiren;Alain Thibault;Hans J De Haard;20142014, vol.6, no.2
Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potencyLouise Saul;Debra H Josephs;Keith Cutler;Andrew Bradwell;Panagiotis Karagiannis;Chris Selkirk;Hannah J Gould;Paul Jones;James F Spicer;Sophia N Karagiannis;20142014, vol.6, no.2
Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycleOrnnuthchar Poungpair;Kunan Bangphoomi;Prapaipit Chaowalit;Nunghathai Sawasdee;Nichapatr Saokaew;Kiattawee Choowongkomon;Wanpen Chaicumpa;Pa-thai Yenchitsomanus;20142014, vol.6, no.2
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer;Pia Glorius;Martin Schlaeth;Stefan Lohse;Katja Klausz;Umesh Muchhal;John R Desjarlais;Andreas Humpe;Thomas Valerius;Matthias Peipp;20142014, vol.6, no.2
Assessment of chemical modifications of sites in the CDRs of recombinant antibodiesMarkus Haberger;Katrin Bomans;Katharina Diepold;Michaela Hook;Jana Gassner;Tilman Schlothauer;Adrian Zwick;Christian Spick;Jochen Felix Kepert;Brigitte Hienz;Michael Wiedmann;Hermann Beck;Philipp Metzger;Michael Mølhøj;Constanze Knoblich;Ulla Grauschopf;Dietmar Reusch;Patrick Bulau;20142014, vol.6, no.2
Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencingJavier Valdés-Alemán;Juan Téllez-Sosa;Marbella Ovilla-Muñoz;Elizabeth Godoy-Lozano;Daniel Velázquez-Ramírez;Humberto Valdovinos-Torres;Rosa E Gómez-Barreto;Jesús Martinez-Barnetche;20142014, vol.6, no.2
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cellsJeffrey C Kang;Jayakumar S Poovassery;Pankaj Bansal;Sungyong You;Isabel M Manjarres;Raimund J Ober;E Sally Ward;20142014, vol.6, no.2
9th Annual European Antibody Congress, November 11–13, 2013, Geneva, SwitzerlandJanice M Reichert;Alain Beck;Alexey A Lugovskoy;Thierry Wurch;Steven Coats;Randall J Brezski;20142014, vol.6, no.2
High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopyYuqi Liu;Isabelle Caffry;Jiemin Wu;Steven B Geng;Tushar Jain;Tingwan Sun;Felicia Reid;Yuan Cao;Patricia Estep;Yao Yu;Maximiliano Vásquez;Peter M Tessier;Yingda Xu;20142014, vol.6, no.2
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancerSiqi Han;Yanchun Meng;Qing Tong;Guangchao Li;Xunmin Zhang;Yalin Chen;Shi Hu;Lei Zheng;Wenlong Tan;Hui Li;Yang Chen;Ge Zhang;Bohua Li;Yajun Guo;20142014, vol.6, no.2
123